Bard Medical Shanghai Co., Ltd.:What is Bard Medical Shanghai Co., Ltd. and what does it do?

Q: What is Bard Medical Shanghai Co., Ltd. and what does it do?

A: Bard Medical Shanghai Co., Ltd. is a subsidiary of C.R. Bard, Inc., a global medical technology company now part of Becton, Dickinson and Company (BD). Located in Shanghai, China, this entity focuses on the distribution, marketing, and support of a wide range of medical devices and healthcare products. Its portfolio includes vascular access devices, urology products, surgical specialties, and oncology solutions. The Shanghai subsidiary plays a crucial role in bringing Bard's advanced medical technologies to the Chinese market, collaborating with local hospitals and healthcare providers to improve patient outcomes. By leveraging Bard's global expertise and adapting to local needs, Bard Medical Shanghai Co., Ltd. ensures that healthcare professionals in China have access to high-quality, innovative medical devices. The company also provides training, technical support, and after-sales services to ensure the safe and effective use of its products. As part of BD, it continues to uphold a commitment to advancing healthcare worldwide.

Q: What products and services does Bard Medical Shanghai Co., Ltd. offer?

A: Bard Medical Shanghai Co., Ltd. offers a comprehensive range of medical devices and services tailored to the Chinese healthcare market. Its product lines include vascular access products such as peripherally inserted central catheters (PICCs) and ports, urology products like Foley catheters and ureteral stents, surgical mesh for hernia repair, and biopsy devices for cancer diagnosis. Additionally, the company provides stents and other interventional products for vascular and oncological applications. Beyond products, Bard Medical Shanghai Co., Ltd. delivers extensive clinical support, including training programs for physicians and nurses, educational workshops, and technical assistance during procedures. The company also offers reliable after-sales service, ensuring timely maintenance and supply chain support. By integrating these products and services, Bard Medical Shanghai Co., Ltd. helps healthcare providers enhance patient care, reduce complications, and improve operational efficiency. Its offerings are designed to meet the rigorous standards of the Chinese medical community and comply with local regulations, reflecting a deep understanding of the market's unique requirements.

Q: How does Bard Medical Shanghai Co., Ltd. contribute to healthcare in China?

A: Bard Medical Shanghai Co., Ltd. contributes significantly to healthcare in China by improving access to advanced medical technologies and supporting clinical excellence. Through its extensive distribution network, the company ensures that hospitals and clinics across the country can obtain high-quality medical devices for critical procedures. By partnering with healthcare professionals, Bard Medical Shanghai Co., Ltd. facilitates the adoption of minimally invasive techniques, which can lead to shorter recovery times and better patient outcomes. The company also invests in education and training, organizing seminars and hands-on workshops to help Chinese clinicians stay updated on the latest medical advancements. Furthermore, its presence supports local economies by creating jobs and fostering collaboration with domestic suppliers and distributors. As part of BD, Bard Medical Shanghai Co., Ltd. aligns with global initiatives to combat healthcare-associated infections, improve vascular access safety, and enhance cancer care. Overall, its efforts help elevate the standard of care in China, making a positive impact on patients and the healthcare system as a whole.

Dialogue about

Common scenarios of "Bard Medical Shanghai Co., Ltd."

【Interviewer】 Good morning, Ms. Chen. Thank you for joining us today. Could you start by telling us about Bard Medical Shanghai Co., Ltd.?

【Ms. Chen】 Good morning. Bard Medical Shanghai Co., Ltd. is a subsidiary of C.R. Bard, Inc., a leading multinational medical device company. We focus on developing, manufacturing, and distributing innovative medical devices in China, particularly in vascular, urology, and oncology products.

【Interviewer】 When was the Shanghai facility established, and what was the initial purpose?

【Ms. Chen】 The Shanghai facility was established in 2005 as a manufacturing and distribution hub. Initially, it served to localize production and cater to the growing Chinese healthcare market, reducing reliance on imports.

【Interviewer】 What are the main products manufactured or sold by Bard Medical Shanghai?

【Ms. Chen】 We produce a range of products including vascular grafts, catheters, stents, and urological devices. Our portfolio also includes hernia repair meshes and biopsy systems. All products adhere to global quality standards.

【Interviewer】 How does the Shanghai facility ensure compliance with Chinese regulations and international standards?

【Ms. Chen】 We comply with China's National Medical Products Administration (NMPA) regulations and maintain certifications like ISO 13485 and CE marks. Our quality management system is rigorous, with regular audits and training.

【Interviewer】 Can you describe the company's R&D activities in Shanghai?

【Ms. Chen】 Absolutely. Our Shanghai R&D center focuses on adapting global technologies to meet local needs. For example, we've developed customized vascular stents for Asian patients. We also collaborate with local hospitals and universities on clinical trials.

【Interviewer】 What is the size of the workforce at Bard Medical Shanghai?

【Ms. Chen】 We have approximately 300 employees, including engineers, researchers, production staff, and administrative personnel. About 20% hold advanced degrees, reflecting our commitment to innovation.

【Interviewer】 How does Bard Medical Shanghai contribute to the local community?

【Ms. Chen】 We engage in various CSR activities, such as free health screenings in rural areas, medical training programs for healthcare professionals, and partnerships with charities to improve access to care.

【Interviewer】 What challenges does the company face in the Chinese market?

【Ms. Chen】 Challenges include intense competition from domestic and international players, evolving regulatory landscapes, and pricing pressures due to healthcare reforms. However, we turn these into opportunities by focusing on quality and innovation.

【Interviewer】 How has Bard Medical Shanghai adapted to the COVID-19 pandemic?

【Ms. Chen】 We implemented strict safety protocols, shifted some production to meet pandemic-related demands like catheters for ventilators, and leveraged digital tools for remote collaboration. We also donated supplies to frontline workers.

【Interviewer】 What are your future growth plans for the Shanghai facility?

【Ms. Chen】 We plan to expand our R&D capabilities, increase local manufacturing for cost efficiency, and explore telemedicine and AI-driven diagnostics. Our goal is to become a regional innovation hub for Bard in Asia.

【Interviewer】 How does Bard Medical Shanghai support healthcare professionals?

【Ms. Chen】 We provide extensive training programs, workshops, and on-site support during procedures. We also have a dedicated helpline for product inquiries and technical assistance.

【Interviewer】 What is the company's approach to sustainability?

【Ms. Chen】 We are committed to sustainable practices, such as reducing waste in manufacturing, using eco-friendly packaging, and complying with environmental regulations. We also promote energy efficiency across operations.

【Interviewer】 Thank you, Ms. Chen, for sharing these insights. It's clear that Bard Medical Shanghai is a key player in China's medical device industry.

【Ms. Chen】 Thank you for having me. We are proud of our contributions to healthcare in China and look forward to continued growth and innovation.